|
Aug 30
|
Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update
|
|
May 8
|
Relief Therapeutics Announces New Executive Leadership Team Strengthening Capabilities to Guide the Company through Pipeline Development Initiatives
|
|
Dec 5
|
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
|
|
May 3
|
Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares
|
|
May 1
|
Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA(TM) Commercial Launch Progressing Ahead of Schedule
|
|
Apr 28
|
Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders
|